Daily News Podcast

Smoking tied to localized prostate cancer recurrence, metastasis, death


 

A review and meta-analysis shows that patients with localized prostate cancer who were smokers at the time of local therapy have a high risk of experiencing adverse outcomes and death related to that disease. Also today, teens think their parents approve of marijuana more today than they did in the late 1970’s, switching antimalarials can delay immunosuppressive therapy for patients with cutaneous lupus, and a new reason to eradicate hepatitis C: it can reduce the chance of non-liver cancers.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

MDedge Daily News: Group support, mentorship help combat burnout in female physicians
MDedge Hematology and Oncology
Psoriasis therapy with biologics not linked to increased cancer risk
MDedge Hematology and Oncology
High testosterone in postmenopausal women may add CVD risk
MDedge Hematology and Oncology
Severity of sepsis-associated coagulopathy predicts hospital mortality
MDedge Hematology and Oncology
ACS: Screen for colon cancer at 45
MDedge Hematology and Oncology
TAILORx: Most women with intermediate risk ER+ breast cancer can safely skip chemo
MDedge Hematology and Oncology
What is causing my patients’ macrocytosis?
MDedge Hematology and Oncology
Hip pain predicts arthritis mortality beyond comorbidities
MDedge Hematology and Oncology
Prostate cancer risk before age 55 higher for black men
MDedge Hematology and Oncology
Statin effect in prostate cancer may be caused by reduced inflammation
MDedge Hematology and Oncology